Kellanova Total Revenue vs Research Development Analysis

K Stock

USD 81.17 0.15 0.19%

Kellanova financial indicator trend analysis is infinitely more than just investigating Kellanova recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kellanova is a good investment. Please check the relationship between Kellanova Total Revenue and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.

Total Revenue vs Research Development

Total Revenue vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kellanova Total Revenue account and Research Development. At this time, the significance of the direction appears to have weak relationship.

The correlation between Kellanova's Total Revenue and Research Development is 0.34. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Research Development in the same time period over historical financial statements of Kellanova, assuming nothing else is changed. The correlation between historical values of Kellanova's Total Revenue and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Kellanova are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Total Revenue i.e., Kellanova's Total Revenue and Research Development go up and down completely randomly.

Correlation Coefficient

0.34

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Revenue

Total revenue comprises all receipts Kellanova generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Research Development

Most indicators from Kellanova's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kellanova current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.At this time, Kellanova's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 318.4 M this year, although Enterprise Value Multiple will most likely fall to 8.98.

	2021	2022	2023	2024 (projected)
Gross Profit	4.6B	4.6B	13.1B	13.8B
Total Revenue	14.2B	15.3B	13.1B	10.6B

Gross Profit Total Revenue

Kellanova fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock
Total Assets		0.94	0.57	0.92	0.8	0.97	0.94	0.92	0.48	1.0	0.63	0.48	0.96	-0.83	0.94	0.93	0.38	-0.83	0.99	0.94	0.42	0.9	0.91	0.04	-0.05	-0.05
Short Long Term Debt Total	0.94		0.33	0.82	0.59	0.87	1.0	0.79	0.51	0.95	0.39	0.51	0.9	-0.8	0.99	0.84	0.18	-0.75	0.98	0.86	0.47	0.94	0.8	-0.1	-0.16	-0.16
Other Current Liab	0.57	0.33		0.63	0.66	0.61	0.33	0.64	0.2	0.56	0.83	0.2	0.51	-0.4	0.35	0.57	0.6	-0.59	0.48	0.56	0.06	0.32	0.7	0.17	-0.01	-0.01
Total Current Liabilities	0.92	0.82	0.63		0.75	0.91	0.83	0.89	0.35	0.91	0.55	0.35	0.9	-0.78	0.78	0.93	0.57	-0.81	0.91	0.93	0.62	0.75	0.87	0.11	0.04	0.04
Total Stockholder Equity	0.8	0.59	0.66	0.75		0.85	0.59	0.84	0.3	0.78	0.79	0.3	0.8	-0.63	0.59	0.8	0.56	-0.62	0.69	0.82	0.26	0.6	0.71	0.24	0.12	0.12
Property Plant And Equipment Net	0.97	0.87	0.61	0.91	0.85		0.87	0.92	0.54	0.95	0.68	0.54	0.96	-0.89	0.87	0.91	0.43	-0.84	0.93	0.95	0.45	0.83	0.84	0.18	0.06	0.06
Net Debt	0.94	1.0	0.33	0.83	0.59	0.87		0.78	0.47	0.95	0.39	0.47	0.9	-0.8	0.99	0.84	0.18	-0.75	0.98	0.85	0.47	0.94	0.8	-0.1	-0.15	-0.15
Retained Earnings	0.92	0.79	0.64	0.89	0.84	0.92	0.78		0.5	0.91	0.73	0.5	0.92	-0.77	0.8	0.88	0.43	-0.85	0.88	0.9	0.28	0.71	0.91	0.17	0.13	0.13
Cash	0.48	0.51	0.2	0.35	0.3	0.54	0.47	0.5		0.46	0.29	1.0	0.51	-0.52	0.54	0.44	0.1	-0.42	0.5	0.56	0.15	0.4	0.32	-0.07	-0.12	-0.12
Non Current Assets Total	1.0	0.95	0.56	0.91	0.78	0.95	0.95	0.91	0.46		0.63	0.46	0.95	-0.82	0.95	0.9	0.32	-0.84	0.98	0.91	0.39	0.91	0.92	0.03	-0.06	-0.06
Non Currrent Assets Other	0.63	0.39	0.83	0.55	0.79	0.68	0.39	0.73	0.29	0.63		0.29	0.59	-0.51	0.45	0.55	0.32	-0.65	0.52	0.56	-0.14	0.44	0.72	0.33	0.17	0.17
Cash And Short Term Investments	0.48	0.51	0.2	0.35	0.3	0.54	0.47	0.5	1.0	0.46	0.29		0.51	-0.52	0.54	0.44	0.1	-0.42	0.5	0.56	0.15	0.4	0.32	-0.07	-0.12	-0.12
Net Receivables	0.96	0.9	0.51	0.9	0.8	0.96	0.9	0.92	0.51	0.95	0.59	0.51		-0.84	0.89	0.9	0.37	-0.8	0.94	0.95	0.47	0.82	0.83	0.15	0.1	0.1
Common Stock Shares Outstanding	-0.83	-0.8	-0.4	-0.78	-0.63	-0.89	-0.8	-0.77	-0.52	-0.82	-0.51	-0.52	-0.84		-0.8	-0.77	-0.31	0.91	-0.84	-0.82	-0.44	-0.82	-0.72	-0.43	-0.29	-0.29
Non Current Liabilities Total	0.94	0.99	0.35	0.78	0.59	0.87	0.99	0.8	0.54	0.95	0.45	0.54	0.89	-0.8		0.82	0.13	-0.77	0.97	0.83	0.33	0.94	0.81	-0.09	-0.15	-0.15
Inventory	0.93	0.84	0.57	0.93	0.8	0.91	0.84	0.88	0.44	0.9	0.55	0.44	0.9	-0.77	0.82		0.63	-0.71	0.91	0.97	0.55	0.77	0.79	0.0	-0.08	-0.08
Other Current Assets	0.38	0.18	0.6	0.57	0.56	0.43	0.18	0.43	0.1	0.32	0.32	0.1	0.37	-0.31	0.13	0.63		-0.28	0.31	0.59	0.45	0.16	0.31	0.06	-0.04	-0.04
Other Stockholder Equity	-0.83	-0.75	-0.59	-0.81	-0.62	-0.84	-0.75	-0.85	-0.42	-0.84	-0.65	-0.42	-0.8	0.91	-0.77	-0.71	-0.28		-0.83	-0.75	-0.25	-0.79	-0.89	-0.42	-0.3	-0.3
Total Liab	0.99	0.98	0.48	0.91	0.69	0.93	0.98	0.88	0.5	0.98	0.52	0.5	0.94	-0.84	0.97	0.91	0.31	-0.83		0.91	0.46	0.92	0.88	-0.02	-0.08	-0.08
Total Current Assets	0.94	0.86	0.56	0.93	0.82	0.95	0.85	0.9	0.56	0.91	0.56	0.56	0.95	-0.82	0.83	0.97	0.59	-0.75	0.91		0.56	0.77	0.78	0.07	0.0	0.0
Short Term Debt	0.42	0.47	0.06	0.62	0.26	0.45	0.47	0.28	0.15	0.39	-0.14	0.15	0.47	-0.44	0.33	0.55	0.45	-0.25	0.46	0.56		0.36	0.2	-0.05	-0.09	-0.09
Intangible Assets	0.9	0.94	0.32	0.75	0.6	0.83	0.94	0.71	0.4	0.91	0.44	0.4	0.82	-0.82	0.94	0.77	0.16	-0.79	0.92	0.77	0.36		0.78	0.05	-0.07	-0.07
Accounts Payable	0.91	0.8	0.7	0.87	0.71	0.84	0.8	0.91	0.32	0.92	0.72	0.32	0.83	-0.72	0.81	0.79	0.31	-0.89	0.88	0.78	0.2	0.78		0.13	0.06	0.06
Property Plant And Equipment Gross	0.04	-0.1	0.17	0.11	0.24	0.18	-0.1	0.17	-0.07	0.03	0.33	-0.07	0.15	-0.43	-0.09	0.0	0.06	-0.42	-0.02	0.07	-0.05	0.05	0.13		0.94	0.94
Common Stock Total Equity	-0.05	-0.16	-0.01	0.04	0.12	0.06	-0.15	0.13	-0.12	-0.06	0.17	-0.12	0.1	-0.29	-0.15	-0.08	-0.04	-0.3	-0.08	0.0	-0.09	-0.07	0.06	0.94		1.0
Common Stock	-0.05	-0.16	-0.01	0.04	0.12	0.06	-0.15	0.13	-0.12	-0.06	0.17	-0.12	0.1	-0.29	-0.15	-0.08	-0.04	-0.3	-0.08	0.0	-0.09	-0.07	0.06	0.94	1.0

Click cells to compare fundamentals

Kellanova Account Relationship Matchups

Kellanova fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.6B	18.0B	18.2B	18.5B	15.6B	10.7B
Short Long Term Debt Total	8.5B	8.1B	7.7B	7.2B	6.5B	4.8B
Other Current Liab	1.6B	1.7B	1.6B	2.4B	1.0B	843.6M
Total Current Liabilities	4.8B	5.2B	5.3B	6.3B	5.1B	3.2B
Total Stockholder Equity	2.7B	3.1B	3.7B	3.9B	3.2B	2.1B
Property Plant And Equipment Net	4.2B	4.4B	4.5B	4.4B	3.9B	3.3B
Net Debt	8.1B	7.7B	7.4B	6.9B	6.3B	4.5B
Retained Earnings	7.9B	8.3B	9.0B	9.2B	8.8B	4.8B
Cash	397M	435M	286M	299M	274M	281.4M
Non Current Assets Total	14.1B	14.5B	14.8B	14.3B	12.3B	8.3B
Non Currrent Assets Other	908M	1.2B	1.5B	1.3B	961M	663.9M
Cash And Short Term Investments	397M	435M	286M	299M	274M	281.4M
Net Receivables	1.6B	1.5B	1.5B	1.5B	1.6B	999.8M
Common Stock Shares Outstanding	345.6M	348M	343M	345M	344M	325.0M
Liabilities And Stockholders Equity	17.6B	18.0B	18.2B	18.5B	15.6B	10.7B
Non Current Liabilities Total	9.5B	9.1B	8.6B	7.8B	7.2B	5.3B
Inventory	1.2B	1.3B	1.4B	1.8B	1.2B	874.5M
Other Current Assets	232M	226M	221M	1.0B	245M	264.1M
Other Stockholder Equity	(3.8B)	(3.6B)	(3.7B)	(3.7B)	(3.7B)	(3.5B)
Total Liab	14.3B	14.4B	14.0B	14.1B	12.3B	8.5B
Total Current Assets	3.4B	3.5B	3.4B	4.2B	3.3B	2.4B
Short Term Debt	841M	963M	1.1B	1.4B	905M	961.5M
Intangible Assets	2.6B	2.5B	2.4B	2.3B	1.9B	2.0B
Accounts Payable	2.4B	2.5B	2.6B	2.6B	2.3B	1.2B
Property Plant And Equipment Gross	4.2B	4.4B	4.5B	4.4B	8.2B	8.6B
Accumulated Other Comprehensive Income	(1.4B)	(1.7B)	(1.7B)	(1.7B)	(2.0B)	(2.1B)
Other Liab	1.8B	1.9B	1.9B	1.9B	2.1B	1.4B
Other Assets	1.1B	6.2B	1.7B	1.5B	1.7B	1.1B
Long Term Debt	7.2B	6.7B	6.3B	5.3B	5.1B	5.7B
Good Will	5.9B	5.8B	5.8B	5.7B	5.2B	4.7B
Treasury Stock	(4.7B)	(4.6B)	(4.7B)	(4.7B)	(4.2B)	(4.0B)
Property Plant Equipment	3.6B	3.7B	4.5B	4.4B	5.1B	3.7B
Current Deferred Revenue	596M	776M	1.0B	150M	766M	527.9M
Net Tangible Assets	(5.3B)	(4.7B)	(4.5B)	(3.6B)	(3.2B)	(3.4B)
Noncontrolling Interest In Consolidated Entity	567M	524M	495M	434M	499.1M	524.1M
Retained Earnings Total Equity	7.9B	8.3B	9.0B	9.2B	10.6B	7.8B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

How To Invest In Kellanova

Details

Is Kellanova Stock a good investment?

Details

What is Kellanova's Net Worth?

Details

Largest Packaged Foods & Meats Companies

View

Largest Food, Beverage & Tobacco Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Packaged Foods & Meats space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kellanova. If investors know Kellanova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kellanova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.348

Dividend Share

2.25

Earnings Share

2.99

Revenue Per Share

37.415

Quarterly Revenue Growth

(0.01)

The market value of Kellanova is measured differently than its book value, which is the value of Kellanova that is recorded on the company's balance sheet. Investors also form their own opinion of Kellanova's value that differs from its market value or its book value, called intrinsic value, which is Kellanova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kellanova's market value can be influenced by many factors that don't directly affect Kellanova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Kellanova's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kellanova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kellanova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Kellanova Total Revenue vs Research Development Analysis

Total Revenue vs Research Development

Total Revenue vs Research Development Correlation Analysis

Correlation Coefficient

Total Revenue

Research Development

Kellanova fundamental ratios Correlations

Kellanova Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Kellanova fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Total Liab	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total

Accounts Payable	- 0.89	Other Stockholder Equity
Common Stock Shares Outstanding	- 0.89	Property Plant And Equipment Net
Other Stockholder Equity	- 0.85	Retained Earnings
Total Liab	- 0.84	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.84	Net Receivables
Other Stockholder Equity	- 0.84	Non Current Assets Total